Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture
Terren, Carmen; Nisolle, Michelle; Munaut, Carine
2021 • In Journal of Ovarian Research, 14 (1), p. 95
[en] BACKGROUND: Cryopreservation and transplantation of ovarian tissue (OTCTP) represent a promising fertility preservation technique for prepubertal patients or for patients requiring urgent oncological management. However, a major obstacle of this technique is follicle loss due to, among others, accelerated recruitment of primordial follicles during the transplantation process, leading to follicular reserve loss in the graft and thereby potentially reducing its lifespan. This study aimed to assess how cryopreservation itself impacts follicle activation. RESULTS: Western blot analysis of the PI3K/PTEN/Akt and mTOR signalling pathways showed that they were activated in mature or juvenile slow-frozen murine ovaries compared to control fresh ovaries. The use of pharmacological inhibitors of follicle signalling pathways during the cryopreservation process decreased cryopreservation-induced follicle recruitment. The second aim of this study was to use in vitro organotypic culture of cryopreserved ovaries and to test pharmacological inhibitors of the PI3K/PTEN/Akt and mTOR pathways. In vitro organotypic culture-induced activation of the PI3K/PTEN/Akt pathway is counteracted by cryopreservation with rapamycin and in vitro culture in the presence of LY294002. These results were confirmed by follicle density quantifications. Indeed, follicle development is affected by in vitro organotypic culture, and PI3K/PTEN/Akt and mTOR pharmacological inhibitors preserve primordial follicle reserve. CONCLUSIONS: Our findings support the hypothesis that inhibitors of mTOR and PI3K might be an attractive tool to delay primordial follicle activation induced by cryopreservation and culture, thus preserving the ovarian reserve while retaining follicles in a functionally integrated state.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Nisolle, Michelle ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Munaut, Carine ; Université de Liège - ULiège > GIGA Cancer - Tumours and development biology
Language :
English
Title :
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture
Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377(17):1657–65.
Demeestere I, Moffa F, Peccatori F, Poirot C, Shalom-Paz E. Multiple approaches for individualized fertility protective therapy in cancer patients. Obstet Gynecol Int. 2011;2012:1–12.
American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101(5):1237–43. 10.1016/j.fertnstert.2014.02.052. DOI: 10.1016/j.fertnstert.2014.02.052
Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P. Updates in preserving reproductive potential of prepubertal girls with cancer: systematic review. Crit Rev Oncol Hematol. 2016;103:10–21. 10.1016/j.critrevonc.2016.04.002. DOI: 10.1016/j.critrevonc.2016.04.002
Sheshpari S, Shahnazi M, Mobarak H, Ahmadian S, Bedate AM, Nariman-Saleh-Fam Z, et al. Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review. J Transl Med. 2019;17(1):1–15. 10.1186/s12967-019-02149-2. DOI: 10.1186/s12967-019-02149-2
Van DerVen H, Liebenthron J, Beckmann M, Toth B, Korell M, Krüssel J, et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod. 2016;31(9):2031–41.
Lotz L, Dittrich R, Hoffmann I, Beckmann MW. Ovarian tissue transplantation: experience from Germany and worldwide efficacy. Clin Med Insights Reprod Health. 2019;13:1–8. Available from: http://journals.sagepub.com/doi/10.1177/1179558119867357.
Marin L, Bedoschi G, Kawahara T, Oktay KH. History, evolution and current state of ovarian tissue auto-transplantation with cryopreserved tissue: a successful translational research journey from 1999 to 2020. Reprod Sci. 2020. Available from: http://link.springer.com/10.1007/s43032-019-00066-9.
Dolmans M-M. Recent advances in fertility preservation and counseling for female cancer patients. Expert Rev Anticancer Ther. 2018;18(2):115–20. Available from: https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1415758.
Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol. 2015;27(3):222–30.
Donnez J, Dolmans MM, Diaz C, Pellicer A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril. 2015;104(5):1097–8.
Hancke K, Walker E, Strauch O, Göbel H, Hanjalic-Beck A, Denschlag D. Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration? Gynecol Endocrinol. 2009;25(12):839–43.
Baird DT. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196 C. Endocrinology. 1999;140(1):462–71. Available from: https://academic.oup.com/endo/article-lookup/doi/10.1210/en.140.1.462.
Donnez J, Jadoul P, Squifflet J, Van Langendonckt A, Donnez O, Van Eyck AS, et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol. 2010;24(1):87–100. 10.1016/j.bpobgyn.2009.09.003. DOI: 10.1016/j.bpobgyn.2009.09.003
Van Eyck A-S, Jordan BF, Gallez B, Heilier J-F, Van Langendonckt A, Donnez J. Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting. Fertil Steril. 2009;92(1):374–81. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0015028208010650.
Roness H, Gavish Z, Cohen Y, Meirow D. Ovarian follicle burnout: a universal phenomenon? Cell Cycle. 2013;12(20):3245–6.
Masciangelo R, Hossay C, Chiti MC, Manavella DD, Amorim CA, Donnez J, et al. Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue. J Assist Reprod Genet. 2019;10:6–13.
Masciangelo R, Hossay C, Donnez J, Dolmans MM. Does the Akt pathway play a role in follicle activation after grafting of human ovarian tissue? Reprod Biomed Online. 2019;39(2):196–8. 10.1016/j.rbmo.2019.04.007. DOI: 10.1016/j.rbmo.2019.04.007
Gavish Z, Peer G, Hadassa R, Yoram C, Meirow D. Follicle activation and “burn-out” contribute to post-transplantation follicle loss in ovarian tissue grafts: the effect of graft thickness. Hum Reprod. 2014;29(5):989–96.
Henry L, Fransolet M, Labied S, Blacher S, Masereel M-C, Foidart J-M, et al. Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. J Ovarian Res. 2016;9(1):4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4751643&tool=pmcentrez&rendertype=abstract.
Henry L, Labied S, Fransolet M, Kirschvink N, Blacher S, Noel A, et al. Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reprod Biol Endocrinol. 2015;13(1):12. Available from: http://www.rbej.com/content/13/1/12.
Labied S, Delforge Y, Munaut C, Blacher S, Colige A, Delcombel R, et al. Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplant J. 2013;95(3):426–33. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007890-201302150-00004.
Kang BJ, Wang Y, Zhang L, Xiao Z, Li SW. bFGF and VEGF improve the quality of vitrified-thawed human ovarian tissues after xenotransplantation to SCID mice. J Assist Reprod Genet. 2016;33(2):281–9.
Tavana S, Valojerdi MR, Azarnia M, Shahverdi A. Restoration of ovarian tissue function and estrous cycle in rat after autotransplantation using hyaluronic acid hydrogel scaffold containing VEGF and bFGF. Growth Factors. 2016;34(3–4):97–106.
Mahmoodi M, Mehranjani MS, Shariatzadeh SMA, Eimani H, Shahverdi A. Effects of erythropoietin on ischemia, follicular survival, and ovarian function in ovarian grafts. Reproduction. 2014;147(5):733–41.
Mahmoodi M, Mehranjani MS, Shariatzadeh SMA, Eimani H, Shahverdi A. N-acetylcysteine improves function and follicular survival in mice ovarian grafts through inhibition of oxidative stress. Reprod Biomed Online. 2015;30(1):101–10. 10.1016/j.rbmo.2014.09.013. DOI: 10.1016/j.rbmo.2014.09.013
Kolusari A, Okyay AG, Koçkaya EA. The effect of erythropoietin in preventing ischemia-reperfusion injury in ovarian tissue transplantation. Reprod Sci. 2018;25(3):406–13.
Manavella DD, Cacciottola L, Pommé S, Desmet CM, Jordan BF, Donnez J, et al. Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue. Hum Reprod. 2018;33(6):1107–16.
Manavella DD, Cacciottola L, Payen VL, Amorim CA, Donnez J, Dolmans MM. Adipose tissue-derived stem cells boost vascularization in grafted ovarian tissue by growth factor secretion and differentiation into endothelial cell lineages. Mol Hum Reprod. 2019;25(4):184–93.
Cacciottola L, Nguyen TYT, Chiti MC, Camboni A, Amorim CA, Donnez J, et al. Long-term advantages of ovarian reserve maintenance and follicle development using adipose tissue-derived stem cells in ovarian tissue transplantation. J Clin Med. 2020;9(9):2980.
Zhang H, Liu K. Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood. Hum Reprod Update. 2015;21(6):779–86.
Hsueh AJW, Kawamura K, Cheng Y, Fauser BCJM. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36(1):1–24.
Kim JY. Control of ovarian primordial follicle activation. Clin Exp Reprod Med. 2012;39(1):10–4.
Dunlop CE, Anderson RA. The regulation and assessment of follicular growth. Scand J Clin Lab Invest. 2014;74(sup244):13–7. Available from: http://www.tandfonline.com/doi/full/10.3109/00365513.2014.936674.
Gosden RG, Mullan J, Picton HM, Yin H, Tan SL. Current perspective on primordial follicle cryopreservation and culture for reproductive medicine. Hum Reprod Update. 2002;8(2):105–10.
Kawamura K, Kawamura N, Hsueh AJW. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016;28(3):217–22. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001703-201606000-00014.
Kim S-Y, Kurita T. New insights into the role of phosphoinositide 3-kinase activity in the physiology of immature oocytes: lessons from recent mouse model studies. Eur Med J Reprod Health. 2018;3(2):119–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26928661.
Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23677591.
Lee HN, Chang EM. Primordial follicle activation as new treatment for primary ovarian insufficiency. Clin Exp Reprod Med. 2019;46(2):43–9.
Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res. 2000;6(3):880–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10741711.
Zhao Y, Zhang Y, Li J, Zheng N, Xu X, Yang J, et al. MAPK3/1 participates in the activation of primordial follicles through mTORC1-KITL signaling. J Cell Physiol. 2018;233(1):226–37. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jcp.25868.
Adhikari D, Flohr G, Gorre N, Shen Y, Yang H, Lundin E, et al. Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles. Mol Hum Reprod. 2009;15(12):765–70.
Adhikari D, Zheng W, Shen Y, Gorre N, Hämäläinen T, Cooney AJ, et al. Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. Hum Mol Genet. 2009;19(3):397–410.
Adhikari D, Liu K. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev. 2009;30(5):438–64.
Xie Y, Li S, Zhou L, Lin H, Jiao X, Qiu Q, et al. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo. Mol Reprod Dev. 2020;87(4):442–53. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/mrd.23330.
Dou X, Sun Y, Li J, Zhang J, Hao D, Liu W, et al. Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice. Aging Cell. 2017;16(4):825–36.
Amorim CA, David A, Dolmans MM, Camboni A, Donnez J, Van Langendonckt A. Impact of freezing and thawing of human ovarian tissue on follicular growth after long-term xenotransplantation. J Assist Reprod Genet. 2011;28(12):1157–65.
Gavish Z, Spector I, Peer G, Schlatt S, Wistuba J, Roness H, et al. Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation. J Assist Reprod Genet. 2018;35(1):61–9.
Dolmans MM, Martinez-Madrid B, Gadisseux E, Guiot Y, Yuan WY, Torre A, et al. Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction. 2007;134(2):253–62.
Silber SJ, DeRosa M, Goldsmith S, Fan Y, Castleman L, Melnick J. Cryopreservation and transplantation of ovarian tissue: results from one center in the USA. J Assist Reprod Genet. 2018;35(12):2205–13. Available from: http://link.springer.com/10.1007/s10815-018-1315-1.
Greve T, Schmidt KT, Kristensen SG, Ernst E, Andersen CY. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue. Fertil Steril. 2012;97(6):1394-1398.e1. 10.1016/j.fertnstert.2012.02.036. DOI: 10.1016/j.fertnstert.2012.02.036
Andersen ST, Pors SE, la Cour Poulsen L, Colmorn LB, Macklon KT, Ernst E, et al. Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review. Fertil Steril. 2019;112(5):908–21. 10.1016/j.fertnstert.2019.07.008. DOI: 10.1016/j.fertnstert.2019.07.008
Celik S, Celikkan FT, Ozkavukcu S, Can A, Celik-Ozenci C. Expression of inhibitor proteins that control primordial follicle reserve decreases in cryopreserved ovaries after autotransplantation. J Assist Reprod Genet. 2018;35(4):615–26.
Ayuandari S, Winkler-Crepaz K, Paulitsch M, Wagner C, Zavadil C, Manzl C, et al. Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspects. J Assist Reprod Genet. 2016;33(12):1585–93. 10.1007/s10815-016-0769-2. DOI: 10.1007/s10815-016-0769-2
Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at-196°C. Hum Reprod. 1994;9(4):597–603. Available from: https://academic.oup.com/humrep/article/612572/Restoration.
Terren C, Fransolet M, Ancion M, Nisolle M, Munaut C. Slow freezing versus vitrification of mouse ovaries: from ex vivo analyses to successful pregnancies after auto-transplantation. Sci Rep. 2019;9(1):19668. Available from: http://www.nature.com/articles/s41598-019-56182-8.
Myers M, Britt KL, Wreford NGM, Ebling FJP, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127(5):569–80.
Grosbois J, Demeestere I. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod. 2018;33(9):1705–14.
Maidarti M, Clarkson YL, Mclaughlin M, Anderson RA, Telfer EE. Inhibition of PTEN activates bovine non-growing follicles in vitro but increases DNA damage and reduces DNA repair response. Hum Reprod. 2019;34(2):297–307.
Adib S, Valojerdi MR, Alikhani M. Dose optimisation of PTEN inhibitor, bpV (HOpic), and SCF for the in-vitro activation of sheep primordial follicles. Growth Factors. 2019;37(3–4):178–89. 10.1080/08977194.2019.1680661. DOI: 10.1080/08977194.2019.1680661
Cheng Y, Kim J, Li XX, Hsueh AJ. Promotion of ovarian follicle growth following mTOR activation: synergistic effects of AKT stimulators. Yan W, editor. PLoS One. 2015;10(2):e0117769. 10.1371/journal.pone.0117769. DOI: 10.1371/journal.pone.0117769
Kong HS, Kim SK, Lee J, Youm HW, Lee JR, Suh CS, et al. Effect of exogenous anti-Müllerian hormone treatment on cryopreserved and transplanted mouse ovaries. Reprod Sci. 2016;23(1):51–60. Available from: http://journals.sagepub.com/doi/10.1177/1933719115594021.
Liu W, Zhang J, Wang L, Liang S, Xu B, Ying X, et al. The protective effects of rapamycin pretreatment on ovarian damage during ovarian tissue cryopreservation and transplantation. Biochem Biophys Res Commun. 2021;534:780–6. 10.1016/j.bbrc.2020.10.110. DOI: 10.1016/j.bbrc.2020.10.110
Hu L-L, Su T, Luo R-C, Zheng Y-H, Huang J, Zhong Z-S, et al. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice. J Cell Physiol. 2018;234(2):1578–87. Available from: http://doi.wiley.com/10.1002/jcp.27024.
Barberino RS, Santos JMS, Lins TLBG, Menezes VG, Monte APO, Gouveia BB, et al. Epigallocatechin-3-gallate (EGCG) reduces apoptosis of preantral follicles through the phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) signaling pathway after in vitro culture of sheep ovarian tissue. Theriogenology. 2020;155:25–32. 10.1016/j.theriogenology.2020.05.037. DOI: 10.1016/j.theriogenology.2020.05.037
Grosbois J, Devos M, Demeestere I. Implications of nonphysiological ovarian primordial follicle activation for fertility preservation. Endocr Rev. 2020;41(6):1–26.
Grabinski N, Ewald F, Hofmann BT, Staufer K, Schumacher U, Nashan B, et al. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer. 2012;11(1):85. Available from: http://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-11-85.
O’Reilly KE, Rojo F, She Q-B, Solit D, Mills GB, Smith D, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006;66(3):1500–8. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-05-2925.
Yang S, Xiao X, Meng X, Leslie KK. A mechanism for synergy with combined mTOR and PI3 kinase inhibitors. Bernhard EJ, editor. PLoS One. 2011;6(10):e26343. 10.1371/journal.pone.0026343. DOI: 10.1371/journal.pone.0026343
Alten HE, Groscurth P. The postnatal development of the ovary in the “nude” mouse. Anat Embryol (Berl). 1975;148(1):35–46.
Canning J, Takai Y, Tilly JL. Evidence for genetic modifiers of ovarian follicular endowment and development from studies of five inbred mouse strains. Endocrinology. 2003;144(1):9–12.
Faddy M, Gosden R. Let’s not ignore the statistics. Biol Reprod. 2009;81(1):231–2.
Pepling ME, Sundman EA, Patterson NL, Gephardt GW, Medico L, Wilson KI. Differences in oocyte development and estradiol sensitivity among mouse strains. Reproduction. 2010;139(2):349–57.
Campos-Junior PHA, Assuncao CM, Carvalho BC, Batista RITP, Garcia RMG, Viana JHM. Follicular populations, recruitment and atresia in the ovaries of different strains of mice. Reprod Biol. 2012;12(1):41–55. 10.1016/S1642-431X(12)60076-X. DOI: 10.1016/S1642-431X(12)60076-X
Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol. 1989;11:61–109.
Morabia A. International variability in ages at menarche, first livebirth, and menopause. Am J Epidemiol. 1998;148(12):1195–205.
Tuttle AH, Philip VM, Chesler EJ, Mogil JS. Comparing phenotypic variation between inbred and outbred mice. Nat Methods. 2018;15(12):994–6. Available from: http://www.nature.com/articles/s41592-018-0224-7.
Zhang XM, Li L, Xu JJ, Wang N, Liu WJ, Lin XH, et al. Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression. Gene. 2013;523(1):82–7.
Sato Y, Kawamura K. Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice. Mol Cell Endocrinol. 2020;504(August 2019):110694. 10.1016/j.mce.2019.110694. DOI: 10.1016/j.mce.2019.110694
Adhikari D, Risal S, Liu K, Shen Y. Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling. Kim S, editor. PLoS One. 2013;8(1):e53810. 10.1371/journal.pone.0053810. DOI: 10.1371/journal.pone.0053810
Bezerra MÉS, Barberino RS, Menezes VG, Gouveia BB, Macedo TJS, Santos JMS, et al. Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signalling pathway. Reprod Fertil Dev 2018;30(11):1503–13. Available from: http://www.publish.csiro.au/?paper=RD17332.
Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res. 2000;6(3):880 LP – 886.